Stocks · Health care · Pharmaceutical Preparations

Wave Life Sciences, Inc.

WVE Clue Score51
United States Fiscal year ends December CIK 0001631574 Results filed 27 Oct 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Ra Capital Management, L.p.
30 Mar 2026
Director
Buy indirect
971,091
$6.50
$6.31M
Ra Capital Management, L.p.
27 Mar 2026
Director
Buy indirect
2,495,623
$6.43
$16.05M
Ra Capital Management, L.p.
26 Mar 2026
Director
Buy indirect
351,224
$6.38
$2.24M
Ra Capital Management, L.p.
26 Mar 2026
Director
Buy indirect
4,954,558
$6.06
$30.02M
GSK plc
11 Dec 2025
10% owner
Buy indirect
1,470,000
$19.00
$27.93M
Ra Capital Management, L.p.
13 Nov 2025
Director
Buy indirect
1,000
$6.69
$6.69K

What was left out

Form 4 filings counted 31
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 3
Sales on a Rule 10b5-1 plan 8
Sales straight out of an exercise 35
Sales at will 4
Transactions with no price 0
Shares from compensation/vesting 5,330,778
History held since 18 Nov 2015